Evidence map›Paper›PMID 34131543›Full record

ArticleCureus2021

Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital.

Krista Yazareth Enríquez López, José Meneses Calderón, Lilia de la Cruz Ávila, Miguel Ángel López Esquivel, Jazmín Meneses Figueroa, María José Vargas Contreras, José Anaya Herrera, Ofelia Roxana Sotelo Martínez, José Antonio Mendoza López, Hugo Mendieta Zerón

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Krista Yazareth Enríquez LópezDepartment of Obstetrics and Gynaecology, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
José Meneses CalderónDepartment of Research, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
Lilia de la Cruz ÁvilaDepartment of COVID, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
Miguel Ángel López EsquivelDepartment of Telemedicine, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
Jazmín Meneses FigueroaLaboratory of Genetics, Faculty of Medicine, Autonomous University of the State of Mexico, Toluca, MEX.
María José Vargas ContrerasLaboratory of Genetics, Faculty of Medicine, Autonomous University of the State of Mexico, Toluca, MEX.
José Anaya HerreraDepartment of Obstetrics and Gynaecology, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
Ofelia Roxana Sotelo MartínezResearch and Teaching Unit, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
José Antonio Mendoza LópezReseach and Teaching Unit, "Mónica Pretelini Sáenz" Maternal-Perinatal Hospital, Toluca, MEX.
Hugo Mendieta ZerónFaculty of Medicine, Autonomous University of the State of Mexico, Toluca, MEX.
Universidad Autónoma del Estado de México · MXMaternal Perinatal Hospital Mónica Pretelini · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Nitazoxanide shows adequate

Indexed as

covid-19nitazoxanidepregnancypuerperium

Identifiers

PMID34131543
PMCPMC8196550
OpenAlexW3160220875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.